|
AU2300699A
(en)
|
1998-02-17 |
1999-08-30 |
Ono Pharmaceutical Co. Ltd. |
Amidino derivatives and drugs containing the same as the active ingredient
|
|
US20030134853A1
(en)
*
|
2001-09-26 |
2003-07-17 |
Priestley Eldon Scott |
Compounds useful for treating hepatitis C virus
|
|
US7285680B2
(en)
|
2002-05-28 |
2007-10-23 |
Ono Pharmaceutical Co., Ltd. |
β-alanine derivatives and the use thereof
|
|
EP1553075B1
(en)
|
2002-10-03 |
2013-08-14 |
Ono Pharmaceutical Co., Ltd. |
Lpa receptor antagonists
|
|
TW200521108A
(en)
|
2003-12-19 |
2005-07-01 |
Ono Pharmaceutical Co |
Compounds having lysophosphatidic acid receptor(LPA)-antagonizing effect and their use
|
|
FR2874379B1
(fr)
|
2004-08-17 |
2006-10-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
MX2007001943A
(es)
|
2004-08-17 |
2007-05-09 |
Galderma Res & Dev |
Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
|
|
US20070032488A1
(en)
|
2005-08-05 |
2007-02-08 |
Genelabs Technologies, Inc. |
6-Membered aryl and heteroaryl derivatives for treating viruses
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
WO2012078593A2
(en)
|
2010-12-07 |
2012-06-14 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists and uses thereof
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
US20130122297A1
(en)
|
2011-10-24 |
2013-05-16 |
Northwestern University |
Molecular gauge blocks for building on the nanoscale
|
|
WO2013070879A1
(en)
|
2011-11-10 |
2013-05-16 |
Bristol-Myers Squibb Company |
Methods for treating spinal cord injury with lpa receptor antagonists
|
|
SG11201407220YA
(en)
|
2012-06-20 |
2014-12-30 |
Hoffmann La Roche |
N-alkyltriazole compounds as lpar antagonists
|
|
SG11201507459YA
(en)
|
2013-03-15 |
2015-10-29 |
Epigen Biosciences Inc |
Heterocyclic compounds useful in the treatment of disease
|
|
PT3013796T
(pt)
|
2013-06-27 |
2020-03-26 |
Lg Chemical Ltd |
Derivados biarílicos como agonistas de gpr120
|
|
US10099981B2
(en)
|
2015-03-31 |
2018-10-16 |
University Of Georgia Research Foundation, Inc. |
Methods for meta-arylation of aromatic alcohols
|
|
EP3344619B1
(en)
|
2015-09-04 |
2020-10-28 |
H. Hoffnabb-La Roche Ag |
Phenoxymethyl derivatives
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
WO2019041340A1
(en)
|
2017-09-04 |
2019-03-07 |
Eli Lilly And Company |
LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1)
|
|
JP7369125B2
(ja)
|
2017-12-19 |
2023-10-25 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのイソキサゾールo-架橋カルバモイルシクロヘキシル酸
|
|
JP7202383B2
(ja)
|
2017-12-19 |
2023-01-11 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのピラゾールo-架橋カルバモイルシクロヘキシル酸
|
|
WO2019126087A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as lpa antagonists
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
CA3085561A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid triazole azines as lpa antagonists
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
CN111712492B
(zh)
|
2017-12-19 |
2024-05-31 |
百时美施贵宝公司 |
作为lpa拮抗剂的环己基酸三唑唑类
|
|
ES2962367T3
(es)
|
2017-12-19 |
2024-03-18 |
Bristol Myers Squibb Co |
Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA)
|
|
US11319309B2
(en)
|
2017-12-19 |
2022-05-03 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as LPA antagonists
|
|
KR102725744B1
(ko)
|
2017-12-19 |
2024-11-01 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 피라졸 아진
|
|
EP3807254A4
(en)
*
|
2018-06-18 |
2022-03-23 |
Epigen Biosciences, Inc. |
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
|
|
KR102800284B1
(ko)
|
2018-09-18 |
2025-04-23 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헵틸 산
|
|
JP7412424B2
(ja)
|
2018-09-18 |
2024-01-12 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのオキサビシクロ酸
|
|
ES2946657T3
(es)
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
CN111434653A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
三氮唑类化合物及其制备方法与用途
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
US12466804B2
(en)
|
2019-06-18 |
2025-11-11 |
Bristol-Myers Squibb Company |
Cyclobutyl carboxylic acids as LPA antagonists
|
|
EP3986552B1
(en)
|
2019-06-18 |
2024-09-18 |
Bristol-Myers Squibb Company |
Isoxazole carboxylic acids as lpa antagonists
|
|
KR20220024548A
(ko)
|
2019-06-18 |
2022-03-03 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 트리아졸 카르복실산
|
|
IL289951B2
(en)
|
2019-07-30 |
2025-10-01 |
Taisho Pharmaceutical Co Ltd |
Urea compound as an LPA1 receptor antagonist
|
|
US20230061417A1
(en)
|
2019-12-12 |
2023-03-02 |
Chiesi Farmaceutici S.P.A. |
Thienopyrimidine derivatives as lpa receptor 2 inhibitors
|
|
JP2023505703A
(ja)
|
2019-12-12 |
2023-02-10 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
Lpa受容体2阻害剤としての芳香族アミド誘導体
|
|
IL300525A
(en)
|
2020-08-11 |
2023-04-01 |
Viva Star Biosciences Ltd |
Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists
|
|
WO2022083703A1
(en)
|
2020-10-22 |
2022-04-28 |
Lhotse Bio, Inc. |
Compounds and compositions for treating conditions associated with lpa receptor activity
|
|
WO2022100623A1
(zh)
|
2020-11-10 |
2022-05-19 |
武汉人福创新药物研发中心有限公司 |
氮取代杂环噻吩类化合物及其用途
|
|
WO2022100625A1
(zh)
|
2020-11-10 |
2022-05-19 |
武汉人福创新药物研发中心有限公司 |
氮取代氨基碳酸酯噻吩类化合物及其用途
|
|
CN114621135B
(zh)
|
2020-12-11 |
2024-01-30 |
上海拓界生物医药科技有限公司 |
一种lpa1小分子拮抗剂
|
|
US20240190860A1
(en)
|
2021-03-24 |
2024-06-13 |
Chiesi Farmaceutici S.P.A. |
8-cyclo-substituted quinazoline derivatives as lpa receptor 2 inhibitors
|
|
KR20240038004A
(ko)
|
2021-07-20 |
2024-03-22 |
투오지에 바이오텍 (상하이) 컴퍼니 리미티드 |
Lpa1 소분자 길항제
|
|
JP2024540937A
(ja)
|
2021-10-21 |
2024-11-06 |
ローツェ・バイオ・インコーポレイテッド |
Lpa受容体活性に関連する状態を処置するための化合物および組成物
|
|
TW202342017A
(zh)
*
|
2022-02-25 |
2023-11-01 |
美商洛子峰生物有限公司 |
用於治療與lpa受體活性相關的病狀的化合物及組合物
|
|
JP2025540714A
(ja)
|
2022-11-24 |
2025-12-16 |
ローツェ・バイオ・インコーポレイテッド |
Lpa受容体活性と関連する状態を処置するための化合物および組成物
|